CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Rivanna Medical announced today that it has begun selling its Accuro device to anesthesia providers as a result of a successful product launch at the annual ...
• and predicts needle direction and distance from the skin to reach target structures. As reported in the study, a patient requesting epidural analgesia for labor presented with a calculated BMI of 64 ...
Rivanna, developers of world-first, imaging-based medical solutions, have entered into a partnership with Tri-anim Health Services, a specialty distributor of respiratory, anesthesia, and ...
CHARLOTTESVILLE, Va., Dec. 16, 2025 /PRNewswire/ -- RIVANNA®, developer of world-first imaging-based medical technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted ...
CHARLOTTESVILLE, Va., July 16, 2025 /PRNewswire/ -- RIVANNA ®, developers of world-first imaging-based medical technologies, announced that it has received 510(k) clearance from the U.S. Food and Drug ...
CHARLOTTESVILLE, Va., Oct. 21, 2025 /PRNewswire/ -- RIVANNA®, developers of world-first imaging-based medical technologies, has been awarded with a Peer-Reviewed Medical Research Program (PRMRP) ...
Rivanna Medical, a commercial-stage medical device company that has developed a platform of technologies based on medical ultrasound, announced today that it has appointed John A. Williams as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results